Last updated 2026-07-20
Total raised
—
Stage
Pre-Funding
Founded
—
Headcount
—
HQ
Haifa, Israel
Sector
Health Tech & Life Sciences
About
Libaccord is the developer of an innovative device for treating ventricular and atrial arrhythmias using super-cooled liquid nitrogen. Based on the deepest possible ablation (transmural), the companys solution uses the novel clinical approach of scar homogenization to reduce procedure time and includes built-in ablation depth feedback to ensure performance and safety.
Offices
Haifa, Israel · HQ / main office
Q&A
- What is Libaccord's primary focus?
- Libaccord develops an innovative device for treating ventricular and atrial arrhythmias using super-cooled liquid nitrogen.
- What clinical approach does Libaccord's solution utilize?
- Libaccord's solution uses the novel clinical approach of scar homogenization to reduce procedure time and includes built-in ablation depth feedback.
- When was Libaccord founded?
- Libaccord was founded in March 2020.
- Where is Libaccord's headquarters located?
- Libaccord's headquarters is located in Haifa, Israel.
- Who are the co-founders of Libaccord?
- The co-founders of Libaccord are Gregory Golovchiner and Yakov Nedlin.
- What is Libaccord's current funding stage?
- Libaccord is currently in the Pre-Funding stage.
- Does Libaccord hold any patents?
- Yes, Libaccord holds one patent.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
heart-failurecardiovascularhospitalscatheterstreatmentscardiologymedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | libaccord.com/ |
|---|
Radar intelligence
Web history (Wayback)
| Domain | libaccord.com |
|---|
Certificate / subdomain footprint
| Subdomains | 9 |
|---|